Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil

BACKGROUND: The docetaxel, 5-fluorouracil, and cisplatin (DCF) regimen is an effective form of chemotherapy for advanced esophageal cancer. However, the incidence of adverse events such as febrile neutropenia and hematological toxicity is high. METHODS: Among 937 patients with esophageal cancer at T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkura, Yu, Ueno, Masaki, Udagawa, Harushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637474/
https://www.ncbi.nlm.nih.gov/pubmed/31315622
http://dx.doi.org/10.1186/s12957-019-1665-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637474/
https://www.ncbi.nlm.nih.gov/pubmed/31315622
http://dx.doi.org/10.1186/s12957-019-1665-x

Ejemplares similares